Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finasteride vs Cyproterone Acetate for TURP Blood Loss
NCT04848181Phase 1Completed
- Sponsor
- Benha University
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of finasteride and cyproterone in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Benha University. Primary endpoints: Post-operative Hemoglobin, Post-operative Hematocrit and 3 more. Started Jul 2019; status: completed.
02
Drugs
finasteridecyproterone
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT04848181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04848181.